226 related articles for article (PubMed ID: 25665470)
21. Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer.
Dimitriadis E; Kalogeropoulos T; Velaeti S; Sotiriou S; Vassiliou E; Fasoulis L; Klapsas V; Synesiou M; Apostolaki A; Trangas T; Pandis N
Anticancer Res; 2013 Jan; 33(1):191-7. PubMed ID: 23267145
[TBL] [Abstract][Full Text] [Related]
22. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
[TBL] [Abstract][Full Text] [Related]
23. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
[TBL] [Abstract][Full Text] [Related]
24. DNA-based detection of prostate cancer in urine after prostatic massage.
Goessl C; Müller M; Heicappell R; Krause H; Straub B; Schrader M; Miller K
Urology; 2001 Sep; 58(3):335-8. PubMed ID: 11549474
[TBL] [Abstract][Full Text] [Related]
25. Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker.
Zare M; Jazii FR; Alivand MR; Nasseri NK; Malekzadeh R; Yazdanbod M
BMC Cancer; 2009 Jan; 9():24. PubMed ID: 19149902
[TBL] [Abstract][Full Text] [Related]
26. Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
Rouprêt M; Hupertan V; Catto JW; Yates DR; Rehman I; Proctor LM; Phillips J; Meuth M; Cussenot O; Hamdy FC
Int J Cancer; 2008 Feb; 122(4):952-6. PubMed ID: 17960617
[TBL] [Abstract][Full Text] [Related]
27. Gene promoter methylation and its potential relevance in early prostate cancer diagnosis.
Steiner I; Jung K; Schatz P; Horns T; Wittschieber D; Lein M; Dietel M; Erbersdobler A
Pathobiology; 2010; 77(5):260-6. PubMed ID: 21116117
[TBL] [Abstract][Full Text] [Related]
28. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.
Dulaimi E; Uzzo RG; Greenberg RE; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Mar; 10(6):1887-93. PubMed ID: 15041703
[TBL] [Abstract][Full Text] [Related]
29. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.
Enokida H; Shiina H; Urakami S; Terashima M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Igawa M; Dahiya R
Cancer; 2006 Jan; 106(1):79-86. PubMed ID: 16323173
[TBL] [Abstract][Full Text] [Related]
30. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
[TBL] [Abstract][Full Text] [Related]
31. Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging.
Bakavicius A; Daniunaite K; Zukauskaite K; Barisiene M; Jarmalaite S; Jankevicius F
Clin Epigenetics; 2019 Aug; 11(1):115. PubMed ID: 31383039
[TBL] [Abstract][Full Text] [Related]
32. GSTP1 CpG island hypermethylation for DNA-based detection of occult tumor cells in surgical margins after radical prostatectomy.
Jentzmik F; Krause H; Reichelt U; Schrader AJ; Schrader M; Baumunk D; Cash H; Miller K; Schostak M
World J Urol; 2012 Aug; 30(4):541-6. PubMed ID: 21947551
[TBL] [Abstract][Full Text] [Related]
33. DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer.
Litovkin K; Van Eynde A; Joniau S; Lerut E; Laenen A; Gevaert T; Gevaert O; Spahn M; Kneitz B; Gramme P; Helleputte T; Isebaert S; Haustermans K; Bollen M
PLoS One; 2015; 10(6):e0130651. PubMed ID: 26086362
[TBL] [Abstract][Full Text] [Related]
34. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K
Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508
[TBL] [Abstract][Full Text] [Related]
35. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
[TBL] [Abstract][Full Text] [Related]
36. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.
Lin X; Tascilar M; Lee WH; Vles WJ; Lee BH; Veeraswamy R; Asgari K; Freije D; van Rees B; Gage WR; Bova GS; Isaacs WB; Brooks JD; DeWeese TL; De Marzo AM; Nelson WG
Am J Pathol; 2001 Nov; 159(5):1815-26. PubMed ID: 11696442
[TBL] [Abstract][Full Text] [Related]
37. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients.
Aykanli E; Arisan S; Arisan ED; Yavuzsan AH
Urol J; 2024 May; 21(3):182-188. PubMed ID: 38493315
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
40. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
Cairns P; Esteller M; Herman JG; Schoenberg M; Jeronimo C; Sanchez-Cespedes M; Chow NH; Grasso M; Wu L; Westra WB; Sidransky D
Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]